Impact Of Growing Preterm Births On The Market Growth: Pivotal Factor Influencing Pediatric Drugs Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pediatric Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size of pediatric drugs has witnessed swift expansion in the past few years. The market is projected to increase from $157 billion in 2024 to $179.43 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 14.3%. Factors influencing growth in the past include the need for relevant medications, high demand due to a significant pediatric population, increased awareness of pediatric diseases, growth in pediatric oncology, the advent of digital health and telemedicine, and heightened cooperation in the development of pediatric drugs.

How Will the Pediatric Drugs Market Size Evolve and Grow by 2029?
The market for pediatric drugs is anticipated to experience a swift expansion in the near future, reaching a value of "$308.57 billion by 2029 with a compound annual growth rate (CAGR) of 14.5%. This surge over the projection period can be linked to factors like an increasing pediatric populace, a growing occurrence of mental health issues in children, a rising number of children grappling with chronic diseases, an increased rate of vaccinations among children, and escalating demand for medications related to pediatric mental health. Key trends influencing this period are personalized medication for children, the inclusion of technology in the delivery of pediatric medicine, digital health solutions and telemedicine, increased pediatric clinical trials, and a boosted collaboration between pediatricians and pharmacists.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

What Drivers Are Propelling the Growth of Pediatric Drugs Market Forward?
The pediatric drugs market is expected to expand on account of the increasing number of preterm births. These are births occurring before the 37 weeks of pregnancy, rather than after the normal 40 weeks. The growing trend of preterm births can be traced back to numerous elements such as elevating maternal age, specific lifestyle choices, certain clinical conditions, multiple pregnancies, and inadequate prenatal care. Pediatric drugs play a crucial role in promoting the health and growth of preterm babies by providing bespoke interventions for issues like respiratory disorders, infections, and deficiencies in nutrition. As per a study released by Tommy's, a charity organization based in the UK, in December 2022, the proportion of premature live births in England and Wales in 2022 was noted at 7.9%, rising from 7.5% in 2021. This indicates that over 53,000 babies were born prematurely in 2022. Consequently, the swelling numbers of preterm births are fueling the growth of the pediatric drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

What Are the Key Trends Driving Pediatric Drugs Market Growth?
Key players in the pediatric drugs market are turning their focus towards the development of innovative medications, including fully human monoclonal antibodies. These newly developed drugs aim to enhance treatment effectiveness while reducing side effects in child patients. A fully human monoclonal antibody (mAb) is generated entirely from human genetic sequences, which significantly lowers the chance for the immune system to react in comparison to chimeric or humanized monoclonal antibodies. Such antibodies are synthesized using cutting-edge biotechnology methods, like the use of transgenic mice possessing human antibody genes or phage display technology. For example, Johnson and Johnson, a pharmaceutical company based in the United States, obtained FDA approval for STELARA (ustekinumab) to treat pediatric patients six years and older who have active psoriatic arthritis (PsA) in August 2022. This approval marks a massive leap as STELARA is the only biologic therapy that targets interleukin-12 (IL-12) and interleukin-23 (IL-23), crucial cytokines in inflammatory responses linked with autoimmune diseases. Active PsA impacts about 5-8% of children with chronic inflammatory arthritis, causing symptoms such as joint inflammation and skin lesions.

What Are the Key Segments in the Pediatric Drugs Market?
The pediatric drugs market covered in this report is segmented -

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs
2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids
2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)
3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives
4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp

Who Are the Key Players Shaping the Pediatric Drugs Market's Competitive Landscape?
Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

What Geographic Markets Are Powering Growth in the Pediatric Drugs Market?
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.